The AIM-HI Women’s Venture Competition provides women-led oncology startups with lifeline seed funding, important coaching, and continuous access to our global network. NFCR is proud to be a founding partner organization for this program, helping empower women scientist-entrepreneurs in oncology to address unmet medical needs and bring hope to cancer patients worldwide.
The AIM-HI Accelerator Fund (AIM-HI) is an independent 501(C)(3) non-profit organization, established in 2019 with an initial grant from the National Foundation for Cancer Research, with the purpose to accelerate the translation of cancer drug discoveries by investing in seed-stage companies.
